Neuronetics, Inc. (STIM)
Neuronetics, Inc. (STIM)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -10,780 | -7,206 | -9,401 | -22,528 |
| Depreciation and amortization | 745 | 767 | 886 | 1,812 |
| Allowance for credit losses | -267 | 205 | 299 | 83 |
| Inventory impairment | -30 | 121 | 90 | 177 |
| Share-based compensation | 1,677 | 2,181 | 1,409 | 3,258 |
| Non-cash interest expense | 256 | 224 | 212 | 388 |
| Loss on extinguishment of debt | -539 | NaN | NaN | NaN |
| Loss on disposal of property and equipment | -270 | -27 | -2 | -43 |
| Accounts receivable, net | -1,008 | -2,157 | -3,863 | 2,479 |
| Inventory | 432 | 155 | -551 | 791 |
| Net investments in sales-type leases | 43 | 53 | -10 | -12 |
| Prepaid commission expense | -658 | -118 | -227 | -613 |
| Prepaid expenses and other assets | 1,121 | -861 | -457 | -3,356 |
| Accounts payable | 559 | -1,673 | 1,726 | -1,803 |
| Accrued expenses | -2,720 | 2,800 | -1,066 | -2,236 |
| Other liabilities | 170 | 480 | 97 | -320 |
| Deferred revenue | 90 | 54 | -147 | -82 |
| Net cash used in operating activities | -9,421 | 908 | -785 | -20,497 |
| Purchases of property and equipment and capitalized software | 197 | 216 | 114 | 471 |
| Proceeds from the sale of property and equipment | 25 | NaN | NaN | NaN |
| Net cash used in investing activities | -172 | -216 | -114 | -471 |
| Payments of debt issuance costs | NaN | 88 | 80 | NaN |
| Proceeds from issuance of long-term debt | NaN | 0 | 10,000 | NaN |
| Repayment of promissory note | NaN | 211 | NaN | NaN |
| Repayment of deferred and contingent consideration | 250 | 500 | NaN | NaN |
| Proceeds from the issuance of common stock-Secondary Public Offering | NaN | 0 | 20,700 | NaN |
| Payments of common stock offering issuance costs-Secondary Public Offering | NaN | 0 | 1,731 | NaN |
| Proceeds from the issuance of common stock-At Market Equity Offering Program | NaN | 0 | 8,313 | NaN |
| Repayment of long-term debt | 5,000 | NaN | NaN | NaN |
| Payments of common stock offering issuance costs-At Market Equity Offering Program | NaN | 136 | 336 | NaN |
| Payment for debt extinguishment cost | 250 | NaN | NaN | NaN |
| Distribution to non-controlling interest | 77 | 94 | NaN | NaN |
| Proceeds from exercises of stock options | NaN | 0 | 4 | 9 |
| Proceeds from the issuance of common stock | NaN | NaN | NaN | 20,700 |
| Payments of common stock offering issuance costs | NaN | NaN | NaN | 1,731 |
| Net cash (used in) provided by financing activities | -5,577 | -1,029 | 17,901 | 18,978 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -15,170 | -337 | 17,002 | -1,990 |
| Cash and cash equivalents and restricted cash and cash equivalents, beginning of period | 34,134 | 34,471 | 19,459 | NaN |
| Cash and cash equivalents and restricted cash and cash equivalents, end of period | 18,964 | 34,134 | 34,471 | NaN |